4.4 Editorial Material

Adult-onset Still's disease following COVID-19 vaccination

Related references

Note: Only part of the references are listed.
Editorial Material Medicine, General & Internal

18F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine

Julie Steinberg et al.

LANCET (2021)

Article Medicine, General & Internal

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher et al.

Summary: After vaccination with ChAdOx1 nCov-19, rare immune thrombotic thrombocytopenia can occur due to platelet-activating antibodies against PF4, resulting in various thrombotic events. Most patients in this case series were women, with fatal outcomes such as cerebral venous thrombosis and intracranial hemorrhage. Additional studies are needed to further investigate and understand this phenomenon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Immunology

Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination

Abdulla Watad et al.

Summary: Although temporally-associated with SARS-CoV-2 vaccination, new-onset or flare of immune-mediated diseases (IMDs) appear rare. Most cases are of moderate severity and responsive to therapy, although some severe flares occurred.

VACCINES (2021)

Review Medicine, General & Internal

Adult-onset Still's disease complications

M. Fauter et al.

REVUE DE MEDECINE INTERNE (2020)

Review Rheumatology

Mechanisms, biomarkers and targets for adult-onset Still's disease

Eugen Feist et al.

NATURE REVIEWS RHEUMATOLOGY (2018)

Article Rheumatology

Onset of adult-onset Still’s disease following influenza vaccination

Katsunobu Yoshioka et al.

Modern Rheumatology (2014)